Search results
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives.
- 169.42Add to watchlist+0.85 (+0.50%)At close: Fri. Jun 7, 2024 4:00 PM EDT · Delayed Quote (USD) · Market closed
- Open169.00High170.34Low167.79
- Mkt Cap299.17BP/E (TTM)50.57Div & Yield6.20 & 3.66%
- Prev. Close168.5752 Wk. Low130.9652 Wk. High182.89
What analysts are sayingTop storiesAbbVie's (ABBV) Ovarian Cancer Therapy Meets Study GoalYahoo Finance · 1 day ago- ABBV +0.50%
AbbVie reports positive Phase II ovarian cancer trial dataYahoo Finance · 1 day ago- ABBV +0.50%
Is AbbVie Inc. (NYSE:ABBV) the Most Undervalued Dividend Aristocrat Stock According to Analysts?Yahoo Finance · 2 days agoRelated stocks
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74.
Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing.
Apr 11, 2022 · AbbVie help patients get the medicines and solutions they need through various access and support programs and services, including saving cards, bridge programs and patient assistance programs that provide AbbVie medicines at no cost to eligible patients.
May 7, 2024 · AbbVie discovers and delivers innovative medicines and solutions that enhance people’s lives.
May 7, 2024 · Delivering more than medicine. At AbbVie, we believe everyone should have access to quality and affordable medicines if and when they need them. We help patients get the medicines they need by offering various access and support programs. learn more.
May 7, 2024 · ALPN-101 is a potent inhibitor of both CD28 and ICOS pathways with demonstrated efficacy in multiple preclinical disease models, superior to blockade of either pathway alone. AbbVie and Alpine have entered into an exclusive worldwide option and license agreement for ALPN-101.